No Data
No Data
Checkpoint Therapeutics' Shares Rise After Securing First FDA Approval
FDA Approves Checkpoint Therapeutics' UNLOXCYT for Advanced Cutaneous Squamous Cell Carcinoma
Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT (Cosibelimab-ipdl)
Express News | FDA: Approval of Cosibelimab-Ipdl (Unloxcyt) Granted to Checkpoint Therapeutics
Express News | FDA Approves Cosibelimab-Ipdl for Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma - Website
Express News | Trading Halt: Halted at 5:26:59 P.m. ET - Trading Halt: Halt News Pending
browny_440 : TNXP
UP is the only way : What should be the profit-taking price set for TNXP?
104335410 : what u think bout TRUG, seems like no power